Search

everythinglearnresearchcommunity

for

Search:↓

PRP improves hair transplant results in androgenetic alopecia patients.

Using platelet-rich plasma injections and biotin pills together significantly increases hair regrowth in men with hair loss.

PRP injections may be a safe, effective alternative for hair loss treatment compared to minoxidil and finasteride.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Thyroid disease can cause hair loss and treating thyroid problems might help with hair disorders.

These skin conditions in African men need combined medical treatments and lifestyle changes.

Dermatologists diagnose and manage melanoma more effectively than general practitioners.

Beard hair can be used for hair transplants in severe alopecia cases, with minimal complications and good results.

Levothyroxine is less effective in men with early-onset male-pattern baldness.

The document suggests a possible link between hair loss and thyroid cancer, but doesn't provide definite proof.

GC10/DOX hydrogel shows promise as an effective thyroid cancer treatment.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

The patient with autoimmune hypothyroidism improved after treatment for thyroid and associated conditions.

Finasteride causes temporary cell death in BPH tissues.

People with alopecia have a higher risk of thyroid cancer.

One cat with low thyroid hormone had growth issues, and another with high thyroid hormone had skin problems; both got better with treatment.

The document concludes that understanding nail anatomy is key for diagnosing nail diseases, early signs of nail melanoma may allow for less aggressive treatment, and specific genetic mutations are important in thyroid cancer prognosis and treatment.

Non-scarring hair loss can be diagnosed with two 4mm punch biopsies, one cut vertically and the other transversely.

RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Iodine-deficient diets and antithyroid substances affected rat growth and behavior, but most adapted with positive weight gain.

Retinoids might cause temporary hyperthyroidism in some patients.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

Early subungual melanoma might be treated with less aggressive surgery because it invades the skin under the nail more slowly.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Targeted cancer therapies often cause serious skin problems that need careful management.